Summary of Key Points Core Viewpoint - 康臣药业 has been actively repurchasing its shares, indicating a strategy to support its stock price amidst recent declines [2]. Repurchase Activity - On November 3, 康臣药业 repurchased 201,000 shares at a price range of HKD 15.030 to HKD 15.080, totaling HKD 3.0298 million [2]. - The stock closed at HKD 15.080 on the same day, reflecting a slight increase of 0.33% with a total trading volume of HKD 38.4015 million [2]. - Since October 14, the company has conducted share repurchases for 14 consecutive days, acquiring a total of 3.201 million shares for a cumulative amount of HKD 48.7059 million [2]. - During this period, the stock has experienced a cumulative decline of 5.75% [2]. Year-to-Date Repurchase Summary - Year-to-date, 康臣药业 has executed 32 repurchase transactions, acquiring a total of 8.396 million shares for a total expenditure of HKD 107 million [2]. Detailed Repurchase Data - A detailed table of repurchase activities shows the number of shares repurchased, highest and lowest prices, and total amounts for each transaction from July to November 2025 [3].
康臣药业(01681.HK)11月3日回购302.98万港元，年内累计回购1.07亿港元